101-PGC-005

N/A

Report date: 2025/11/28 16:55:18
NME

Base Information

Drug Name101-PGC-005
Drug Alias Name101-PGC-005101-PGC-005 ('005)'005PGC-005-CP-101
ClassificationSmall molecules > Steroids
Mechanisms of ActionMacrophages inhibitorsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Virus DiseasesCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsraelIndia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator Companies101 Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active Companies101 Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Virus DiseasesCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A